Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2025-09-30
2028-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
MA-CEAL's community engagement (CE) team will act as liaisons and mentors for the CHA's to help guide them and also connect them to opportunities for career/personal development.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
NCT03670524
Community-based Personalized Care and QOL
NCT03263169
Florida Community-Engaged Research Alliance (FL-CEAL)
NCT06829485
Health Impact 360: Advancing Physical, Social, and Mental Health Among Marginalized Communities for Cardiovascular Health Equity
NCT07034352
Community Organizing Network for Environmental Health
NCT00042484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention (Phase A)
Community health centers randomized into this arm will receive study interventions in the first 18 months of the study.
Educating participants about healthcare resources
MA-CEAL team members, including the community health ambassador (CHA), will assist in connecting residents with healthcare resources.
Healthcare appointments
MA-CEAL team members, including the community health ambassador (CHA), will assist residents in making physician appointments.
Workshops
Trained CHAs will provide workshops with information about diabetes and hypertension and how to be screened and get care.
Control (Phase B)
Community health centers randomized into this arm will be wait listed and will not receive study interventions during the first 18 months of the study. They will receive study interventions during the last 12 months of the study.
Educating participants about healthcare resources
MA-CEAL team members, including the community health ambassador (CHA), will assist in connecting residents with healthcare resources.
Healthcare appointments
MA-CEAL team members, including the community health ambassador (CHA), will assist residents in making physician appointments.
Workshops
Trained CHAs will provide workshops with information about diabetes and hypertension and how to be screened and get care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educating participants about healthcare resources
MA-CEAL team members, including the community health ambassador (CHA), will assist in connecting residents with healthcare resources.
Healthcare appointments
MA-CEAL team members, including the community health ambassador (CHA), will assist residents in making physician appointments.
Workshops
Trained CHAs will provide workshops with information about diabetes and hypertension and how to be screened and get care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Speak and understand English and/or Spanish
Exclusion Criteria
* Not a resident of the development
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Massachusetts Community Engaged Alliance (MA-CEAL)
UNKNOWN
Boston Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin Linas, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Boston Medical Center, Infectious Disease
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-45218
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.